Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Trichoscopy is a helpful and quick method to diagnose hair loss without shaving.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

SESA oil is five times more effective and safe for hair and scalp issues than coconut oil.

The document concludes that adult mammalian skin contains multiple stem cell populations with specific markers, important for understanding skin regeneration and related conditions.

Mice lacking a key DNA methylation enzyme in skin cells have a lower chance of activating stem cells necessary for hair growth, leading to progressive hair loss.

Vitamin D Receptor is needed for hair growth in mice but not for skin stem cell maintenance.

Blocking mTORC1 reduces skin tumor growth in mice.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

The we/we wal/wal mice have defects in hair growth and skin layer formation, causing hair loss, useful for understanding alopecia.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Topical minoxidil is effective and safe for hair regrowth in Middle Eastern men with early baldness, with better results in younger patients and certain types of baldness.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

New 5% minoxidil foam effectively promotes hair growth and is safe for use.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Injury changes how hair follicle stem cells behave, depending on the hair growth stage.

Regulating keratinocyte growth in engineered skin can improve wound healing.